Trial Profile
A phase I study to evaluate the safety and tolerability of CAIV-T [influenza virus vaccine live] in healthy Japanese male adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Oct 2009
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors MedImmune
- 31 Oct 2006 Status change
- 14 Dec 2005 New trial record.